Literature DB >> 6328300

Peptide leukotriene release after antigen challenge in patients sensitive to ragweed.

P S Creticos, S P Peters, N F Adkinson, R M Naclerio, E C Hayes, P S Norman, L M Lichtenstein.   

Abstract

Slow-reacting substance of anaphylaxis (composed of leukotrienes C, D, and E) is released in vitro by the interaction of antigen and IgE antibody on human mast cells and basophils. When we challenged ragweed-sensitive patients intranasally with pollen grains, their clinical response was significantly correlated with the release of the peptide leukotrienes (P less than 0.001). Nonallergic subjects had neither symptoms nor leukotriene release. The leukotrienes were released in a dose-dependent fashion, with a peak mean level of 827 +/- 234 pg per 0.1 ml of a 10-ml nasal wash. High-performance liquid chromatography revealed the presence of leukotrienes C, D, and E, suggesting that nasal cells or fluids had the ability to degrade leukotriene C enzymatically. The in vivo release of these potent inflammatory mediators after exposure to pollen suggests that leukotrienes may have an important role in human allergic reactions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328300     DOI: 10.1056/NEJM198406213102502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  39 in total

Review 1.  The role of leukotrienes and antileukotriene agents in the pathogenesis and treatment of allergic rhinitis.

Authors:  R A Simon
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  Synergistic effects of LTB4 and LTD4 on leukocyte emigration into the guinea pig conjunctiva.

Authors:  C S Spada; D F Woodward; S B Hawley; A L Nieves; L S Williams; B J Feldmann
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

3.  Effect of verapamil and sodium cromoglycate on leukotriene D4 induced bronchoconstriction in patients with asthma.

Authors:  J A Roberts; I W Rodger; N C Thomson
Journal:  Thorax       Date:  1986-10       Impact factor: 9.139

Review 4.  Management of anaphylactic and anaphylactoid reactions during anesthesia.

Authors:  B Eon; L Papazian; F Gouin
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

5.  Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma.

Authors:  M K Albazzaz; K R Patel
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

Review 6.  Leukotrienes in inflammation.

Authors:  M A Bray
Journal:  Agents Actions       Date:  1986-10

7.  CGS 22745: a selective orally active inhibitor of 5-lipoxygenase.

Authors:  E Kimble; T Kowalski; D White; A Raychauduri; G Pastor; H Chertock; W Lee; R Neale; A Hamdan; J Wasley
Journal:  Agents Actions       Date:  1991-09

8.  Lung responsiveness to antigen in sensitised mice of different strains.

Authors:  C Zuany-Amorim; M Pretolani; D Leduc; R Cordeiro; B B Vargaftig
Journal:  Agents Actions       Date:  1993

9.  Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on antigen-induced airway responses in neonatally immunized rabbits.

Authors:  C M Herd; D Donigi-Gale; T S Shoupe; D A Burroughs; M Yeadon; C P Page
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

10.  Pathophysiology of nasal congestion.

Authors:  Robert M Naclerio; Claus Bachert; James N Baraniuk
Journal:  Int J Gen Med       Date:  2010-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.